Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer (2013)
- Autores:
- Autores USP: TIÉZZI, DANIEL GUIMARÃES - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP
- Unidade: FMRP
- DOI: 10.6061/clinics/2013(05)03
- Assuntos: NEOPLASIAS; MAMA; QUIMIOTERAPIA; PROGNÓSTICO (FATORES)
- Idioma: Inglês
- Imprenta:
- Fonte:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
TIEZZI, Daniel Guimarães et al. Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer. Clinics, v. 68, n. 5, p. 592-598, 2013Tradução . . Disponível em: https://doi.org/10.6061/clinics/2013(05)03. Acesso em: 25 set. 2024. -
APA
Tiezzi, D. G., Clagnan, W. S., Mandarano, L. R. M., Sousa, C. B. de, Marana, H. R. C., Tiezzi, M. G., & Andrade, J. M. de. (2013). Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer. Clinics, 68( 5), 592-598. doi:10.6061/clinics/2013(05)03 -
NLM
Tiezzi DG, Clagnan WS, Mandarano LRM, Sousa CB de, Marana HRC, Tiezzi MG, Andrade JM de. Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer [Internet]. Clinics. 2013 ; 68( 5): 592-598.[citado 2024 set. 25 ] Available from: https://doi.org/10.6061/clinics/2013(05)03 -
Vancouver
Tiezzi DG, Clagnan WS, Mandarano LRM, Sousa CB de, Marana HRC, Tiezzi MG, Andrade JM de. Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer [Internet]. Clinics. 2013 ; 68( 5): 592-598.[citado 2024 set. 25 ] Available from: https://doi.org/10.6061/clinics/2013(05)03 - Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer
- HIF-1'alfa' and locally advanced breast cancer [Carta]
- Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy
- Clinical criteria as predictive factors of response to primary hormone therapy in locally advanced breast cancer
- Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens
Informações sobre o DOI: 10.6061/clinics/2013(05)03 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 002457740.pdf | Direct link |
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
